Aldagen logo

Aldagen

A company developing regenerative medicines for wound care, inflammation and angiogenesis

2

Funding Rounds

$27.4m

Money raised

Overview

A company developing regenerative medicines for wound care, inflammation and angiogenesis

Funding

Funding series

Funding Series Analysis

The company Aldagen has raised a total of $27.4m in funding over 2 rounds.

Key Insights:

  • Aldagen Series D round: $18.4m
  • Aldagen Series C round: $9m
Aldagen logo
Aldagen Series D round $18.4m
Aldagen logo
Aldagen Series C round $9m

Industries

Aldagen is active in the following industries: